Patent 12023671 was granted and assigned to Pfizer on July, 2024 by the United States Patent and Trademark Office.
Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.